Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,227 | 9,278 | 39,310 | -45,990 | -1,038 |
| Depreciation Amortization | 2,325 | 1,532 | 768 | 3,273 | 2,529 |
| Income taxes - deferred | -6,623 | -5,632 | -4,384 | -346 | 0 |
| Accounts receivable | 2,582 | 1,322 | 1,515 | 46 | 593 |
| Other Working Capital | -1,344 | -239 | 830 | 638 | -633 |
| Other Operating Activity | -16,137 | -25,242 | -47,353 | 11,497 | -26,521 |
| Operating Cash Flow | $-26,424 | $-18,981 | $-9,314 | $-30,882 | $-25,070 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -433 | -364 | -169 | -1,415 | -407 |
| Net Acquisitions | 3,117 | 3,117 | 3,117 | N/A | N/A |
| Sale Of Investment | N/A | N/A | N/A | 3,215 | 3,215 |
| Other Investing Activity | 13,553 | -1 | -2 | 10,016 | -776 |
| Investing Cash Flow | $16,237 | $2,752 | $2,946 | $11,816 | $2,032 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -90 | -84 | -58 | -349 | -256 |
| Common Stock Issued | 63 | -40 | N/A | 6,000 | 6,000 |
| Common Stock Repurchased | N/A | -77 | -74 | -241 | -38 |
| Other Financing Activity | 649 | 744 | 738 | 364 | -26 |
| Financing Cash Flow | $622 | $543 | $606 | $5,774 | $5,680 |
| Exchange Rate Effect | 128 | 83 | 53 | 6 | -40 |
| Beginning Cash Position | 24,399 | 24,399 | 24,399 | 37,685 | 37,685 |
| End Cash Position | 14,962 | 8,796 | 18,690 | 24,399 | 20,287 |
| Net Cash Flow | $-9,437 | $-15,603 | $-5,709 | $-13,286 | $-17,398 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,424 | -18,981 | -9,314 | -30,882 | -25,070 |
| Capital Expenditure | -433 | -364 | -169 | -1,415 | -399 |
| Free Cash Flow | -26,857 | -19,345 | -9,483 | -32,297 | -25,469 |